Clinical Trials Logo

Osteopenia Of Prematurity clinical trials

View clinical trials related to Osteopenia Of Prematurity.

Filter by:
  • None
  • Page 1

NCT ID: NCT06199102 Not yet recruiting - Clinical trials for Vitamin D Deficiency

The High Initial Dose of Monitored Vitamin D Supplementation in Preterm Infants.

HIDVID
Start date: September 1, 2024
Phase: N/A
Study type: Interventional

The aim of this study will be to assess the effectiveness of monitored vit D supplementation in a population of preterm infants and to identify whether the proper vit D supplementation in preterm infants can reduce the incidence of neonatal sepsis and incidence of metabolic bone disease.

NCT ID: NCT04768439 Completed - Clinical trials for Osteopenia of Prematurity

Low and High Doses of Prophylactic Vitamin D in Prevention of Osteopenia of Prematurity

Start date: August 10, 2020
Phase: Phase 2
Study type: Interventional

In this study the effects of low and high doses of prophylactic vitamin D on biochemical and radiological manifestations of osetopenia of prematurity will be tested.

NCT ID: NCT03889717 Recruiting - Clinical trials for Osteopenia of Prematurity

Comparison of Two Different Doses of Vitamin D in Preterm Infants

Start date: April 16, 2019
Phase: N/A
Study type: Interventional

randomized clinical trial comparing two different doses of vitamin d supplementation in preterm infants

NCT ID: NCT03773679 Completed - Clinical trials for Osteopenia of Prematurity

The Effect of Daily Exercise Program on Bone Mineral Density and Cortisol Level in Preterm Infants

Start date: April 15, 2016
Phase: N/A
Study type: Interventional

ABSTRACT Objective: This randomized controlled double-blinded experimental study was carried out to determine the effects of daily exercise program on bone mineral density and cortisol level in preterm infants with very low birth weight matched for birth weight, gestation week, and gender. Study design: The study was performed with preterm infants hospitalized in the neonatal intensive care unit of a tertiary hospital. Ethical committee approval, institutional permission, parental written consent were obtained. Daily exercise program was implemented in preterm infants in the exercise group for 30 days, once a day, and continuing for 7-10 minutes. Before and after the study the following were evaluated in preterm infants in the exercise and control group: anthropometric measurements, tibia speed of sound (SOS) for bone mineral density, serum biochemical parameters and cortisol levels.

NCT ID: NCT01676844 Not yet recruiting - Clinical trials for Osteopenia of Prematurity

Investigating a New Way of Giving Medicine to Newborn and Preterm Babies

Start date: February 2013
Phase: Phase 2
Study type: Interventional

There is a deficit in the number of 'age-appropriate' formulations available for the delivery of medicines to children. Liquid preparations are considered the 'gold standard' for delivering medicines to children however many of these are formulated using ingredients which can be toxic to children (e.g. preservatives, alcohols), particularly to neonatal babies (< 4 weeks old) who do not possess the metabolic processes and mature organ function of older children or adults. Rapidly dissolving oral thin films (OTFs) dissolve quickly in the saliva, releasing the active ingredient(s) without the need for chewing or water, making them ideally suited to patients who find it difficult to swallow other oral dosage forms such as tablets or capsules. The aim of this study is to demonstrate that OTFs can offer a safe and effective alternative for oral administration of phosphate supplements to neonatal infants for the treatment of hypophosphataemia and osteopenia of prematurity. It is hypothesised that this treatment will be equal to standard therapy using an oral solution. Babies born before 32 weeks gestational age are routinely supplemented with oral phosphate as soon as they have been established on oral feeds in order to prevent bone disorders such as osteopenia. Babies recruited to this study will be given phosphate supplementation as per NHS Greater Glasgow and Clyde guidelines. This single-centre cross-over study will take place in the intensive care and special care baby units at the Princess Royal Maternity in Glasgow. The investigators aim to recruit 20-30 babies and will use blood phosphate levels (obtained from routine sampling only) to evaluate treatment effect. Babies will be randomised to receive either OTFs or oral solution of potassium acid phosphate for 2 weeks followed by 2 weeks of the other therapy. The investigators hypothesise that OTF treatment will be equivalent to standard oral solution.

NCT ID: NCT01042639 Recruiting - Clinical trials for Osteopenia of Prematurity

The Effect of Physical Activity on Bone Mineralization and Immune System in Very Low Birth Weight Infants

Start date: January 2010
Phase: N/A
Study type: Interventional

Studies have demonstrated that brief (5-10 min a day) passive range-of-motion exercise is beneficial for bone development in very low birth weight (VLBW) preterm infants. However, the optimal duration and frequency of exercise for bone development in preterm infants is yet unknown. The effect of exercise on the immune system was widely studied in adult and children. Exercise induces increase in IL-6, IL-10, and IL1ra. In adult even 10 minutes of flexion and extension of the wrist cause systemic increase in IL-6. The effect of physical activity on pro and anti inflammatory cytokines in preterm infant was not studied. Objectives: 1. To assess weather twice daily exercise intervention will enhance bone strength compared to once a day intervention 2. To evaluate the effect of a single exercise intervention on inflammatory mediators. Methods: Single center (Meir Medical Center), double blind, randomized control study.

NCT ID: NCT00631397 Completed - Clinical trials for Osteopenia Of Prematurity

A Preliminary Study of Bone Density in Neonates

Start date: March 2007
Phase: N/A
Study type: Observational

The study is to measure how dense or solid the infant's bones are using a new ultrasound machine and how that density changes over time.